That's Good Science!^™ | videos

The immune system doesn't innately recognize that cancer cells are abnormal, but now researchers can genetically modify a person's own immune cells to attack cancer cells. This type of immunotherapy-a treatment that utilizes the inherent power of the immune system-is increasingly recognized as a promising strategy for the treatment of a variety of cancers. With the help of RetroNectin reagent, Dr. Renier Brentjens reprograms patients' own T cells to recognize a leukemia cell antigen. Returning these engineered cells to patients with relapsed lymphoblastic leukemia can lead to remission. That's Good Science!

learn about featured products >>